Literature DB >> 23226628

Patient-centered care in diabetology: From eminence-based, to evidence-based, to end user-based medicine.

Sanjay Kalra1, Magdy H Megallaa, Fatema Jawad.   

Abstract

Entities:  

Year:  2012        PMID: 23226628      PMCID: PMC3510953          DOI: 10.4103/2230-8210.102979

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


× No keyword cloud information.
“Thus I have explained to you knowledge still more confidential. Deliberate on this fully, and then do what you wish to do.” The term patient centered care (PCC) was used over two decades ago, by the Picker Institute to encourage health care professionals to shift focus from disease to patient.[1] The Institute of Medicine, taking this concept further, defined PCC as “care that is respectful of and responsive to individual patient preferences, needs, and values” and that “ensures that patient values guide all clinical decisions”.[2] This definition has been quoted by the recently released diabetes management guidelines as well.[3] While there has been broad acceptance of PCC in diabetes care earlier as well,[4] credit goes to the Diabetes Attitudes, Wishes and Needs (DAWN) movement,[5] and to the nomenclature of the current patient-centered diabetes guidelines[3] for generating global interest in diabetes-related PCC. Many doubts arise regarding the versal applicability of PCC, however. Can physicians transfer all decision making to patients in the name of PCC? Do we abdicate all responsibility, when we move from evidence-based medicine to end user-based management? Do patients have a right to choose outcomes, and make clinical decisions to achieve those outcomes? Is PCC essential in every aspect of diabetes care? Is PCC appropriate for the Asian or African patient, who lives in a society with low literacy levels and suboptimal attitudes towards modern medical care? This editorial explores these grey areas. Many of us initially learnt eminence-based medicine, which gradually gave way to evidence-based medicine (EBM). Did physicians, who shouldered all responsibility for patient wellbeing during the earlier era, then abdicate their duties to clinical trialists and statisticians? Or did their work increase, as they now had to ensure that eminence was concordant with evidence? Similarly, as we move from EBM to end-user based medicine or PCC, will our responsibility decline? Or will we have to meet enhanced expectations, as we work to augment diabetes literacy and numeracy in our patients, improve their communication skills, and ensure that they participate with equipoise in shared decision making (SDM)? Will we have to work harder, or work hardly, if we deal with patients empowered in the real sense of the word? Do patients have a right to choose targets and outcomes, and make clinical decisions? Almost always, the patient does make the final decision. The doctor, at best, can suggest the best possible course of action, during a few-minute long consultation, but it is the patient who walks the talk. In situations in diabetology, which are potentially limb-, sight-, or organ-threatening, or life-threatening, however, the physician should assert charge, and ensure that appropriate medical decisions are made. Though this should not be done in an autocratic manner. An accelerated process of negotiation and motivation should be initiated, support enlisted from family, friends and paramedical staff, and a “finite” trial of appropriate therapy begun.[6] It would do no harm to remember that there are few medical conditions where we are actually sure there is only one correct method of treatment. It is safer, then, to practice SDM, a concept which has been highlighted earlier.[7] SDM is accepted in situations where different “reasonable” paths of action are available. It is the clinician's duty to offer all available options, along with their advantages and disadvantages. At the same time, the empowered patient shoulders responsibility for choosing the most suitable option. And here comes the catch: It is our responsibility to ensure that the patient is empowered and able to choose correctly. Is PCC essential in every aspect of diabetes related decision making? PCC is certainly an essential part of diabetes care, and is mandatory if we are to achieve optimal results. However, in potentially limb-, sight-, organ-, or life-threatening situations, PCC may have limited applicability. Even then, respect for the patient's values must be maintained. The concept of PCC will continuously evolve to address these, and other, issues. Is PCC appropriate for Asia and Africa? AfroAsian cultures tend to have a more holistic view of health and disease, and conflicting views about the etiology of diabetes. Hence, PCC assumes greater importance for us. The low level of literacy in some developing countries, however, is a serious challenge for PCC. PCC and patient empowerment[8] assume a basic level of diabetes literacy, and these should be strengthened by continuous efforts. A recent Australian example of collaboration between health educators and adult literacy teachers can show us the way.[9] Is PCC the end of an evolutionary process in medical care, or a means to an end, viz., good diabetes care? PCC is an evolving concept, whose full prowess is yet to be harnessed. Other, expanded, concepts of PCC, are equally important from an AfroAsian perspective, considering the strong influence of family, community, and culture. Relationship centered care (RCC) is a framework which recognizes that the nature and quality of relationship between patient and provider needs to be given due importance.[10] The best insulin will not work if the patient does not trust the doctor. It becomes the physician's duty, therefore, to ensure a feeling of mutual trust, or reciprocal respect.[11] Another relevant expansion of PCC is family-oriented care (FOC).[12] One should treat the family as a unit, rather than considering the individual patient: This helps ensure optimal lifestyle modification, provides an environment which accepts modern diabetes care, and most importantly, stresses upon diabetes prevention in unaffected family members. The community-oriented approach to diabetes is yet another useful concept for AfroAsian diabetology. The patient of diabetes lives not as an isolated entity, but as part of his or her community.[12] The responsiveness of an individual to the environment surrounding him (both physical and human), is termed as ecosensitivity.[6] Encouragement by the community members and opinion-makers like religious leaders is required to maintain any change in behavior. Emphasis on family and community-oriented care is necessary if diabetology is to fully harness the advantages of PCC in AfroAsia. The impact of PCC can be strengthened if we work towards patient empowerment by improving individual, and community, diabetes literacy and diabetes numeracy. Enhancing patient communication skills also contributes to improving the quality of SDM. At the same time, one should not forget the merits of EBM. It is EBM which has helped diabetology grow over the past few decades into a robust scientific discipline. Much more research, and debate, is required to ensure that EBM and end-user based medicine are able to work together, in a complementary, and effective, manner.
  6 in total

1.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

2.  Shared decision making--pinnacle of patient-centered care.

Authors:  Michael J Barry; Susan Edgman-Levitan
Journal:  N Engl J Med       Date:  2012-03-01       Impact factor: 91.245

Review 3.  Relationship-centered care. A constructive reframing.

Authors:  Mary Catherine Beach; Thomas Inui
Journal:  J Gen Intern Med       Date:  2006-01       Impact factor: 5.128

Review 4.  Reducing the complications of type II diabetes: a patient-centered approach.

Authors:  J L Susman; L D Helseth
Journal:  Am Fam Physician       Date:  1997-08       Impact factor: 3.292

5.  Patient empowerment in endocrinology.

Authors:  Sanjay Kalra; Ambika Gopalkrishnan Unnikrishnan; Soren Eik Skovlund
Journal:  Indian J Endocrinol Metab       Date:  2012-01

6.  Perspectives on patient-centered care in diabetology.

Authors:  Sanjay Kalra; Magdy H Megallaa; Fatema Jawad
Journal:  J Midlife Health       Date:  2012-07
  6 in total
  9 in total

1.  Scalable Architecture for Federated Translational Inquiries Network (SAFTINet) Technology Infrastructure for a Distributed Data Network.

Authors:  Lisa M Schilling; Bethany M Kwan; Charles T Drolshagen; Patrick W Hosokawa; Elias Brandt; Wilson D Pace; Christopher Uhrich; Michael Kamerick; Aidan Bunting; Philip R O Payne; William E Stephens; Joseph M George; Mark Vance; Kelli Giacomini; Jason Braddy; Mika K Green; Michael G Kahn
Journal:  EGEMS (Wash DC)       Date:  2013-10-07

2.  Responsible Patient-centered Care.

Authors:  Sanjay Kalra; Manash P Baruah; A G Unnikrishnan
Journal:  Indian J Endocrinol Metab       Date:  2017 May-Jun

3.  Interaction, Information, Involvement (The 3I strategy): Rebuilding Trust in the Medical Profession.

Authors:  Sanjay Kalra; A G Unnikrishnan; Manash P Baruah
Journal:  Indian J Endocrinol Metab       Date:  2017 Mar-Apr

4.  Logical empiricism in anesthesia: A step forward in modern day clinical practice.

Authors:  Sukhminder Jit Singh Bajwa; Sanjay Kalra
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-04

5.  Chronic disease: Working together.

Authors:  Virve-Ines Laidmäe
Journal:  Indian J Endocrinol Metab       Date:  2013-07

6.  Barriers and solutions to diabetes management: An Indian perspective.

Authors:  Subhash K Wangnoo; Debasish Maji; Ashok Kumar Das; P V Rao; Anand Moses; Bipin Sethi; Ambika Gopalakrishnan Unnikrishnan; Sanjay Kalra; V Balaji; Ganapathi Bantwal; Jothydev Kesavadev; Sunil M Jain; Mala Dharmalingam
Journal:  Indian J Endocrinol Metab       Date:  2013-07

7.  Person centered care in the Second Diabetes Attitudes, Wishes and Needs (DAWN2) study: Inspiration from India.

Authors:  Sanjay Kalra; Manash P Baruah; Rakesh Sahay
Journal:  Indian J Endocrinol Metab       Date:  2014-01

8.  Follow the LEADER-Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial.

Authors:  Sanjay Kalra
Journal:  Diabetes Ther       Date:  2016-09-09       Impact factor: 2.945

9.  Counseling for Growth Hormone Therapy.

Authors:  Sanjay Kalra; Sameer Aggarwal; Ashok Kumar
Journal:  Turk Arch Pediatr       Date:  2021-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.